2021 Q4 Form 10-K Financial Statement

#000095017022005169 Filed on March 31, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $26.64M $91.22M $0.00
YoY Change 26.96%
Cost Of Revenue $11.64M $38.37M
YoY Change 28.23%
Gross Profit $15.00M $52.85M
YoY Change 26.05%
Gross Profit Margin 56.31% 57.94%
Selling, General & Admin $23.26M $81.74M $179.8K
YoY Change 12833.49% 92.36%
% of Gross Profit 155.07% 154.65%
Research & Development $10.67M $32.16M
YoY Change 87.21%
% of Gross Profit 71.13% 60.84%
Depreciation & Amortization $451.0K $1.720M
YoY Change -4.18%
% of Gross Profit 3.01% 3.25%
Operating Expenses $33.93M $113.9M $179.8K
YoY Change 18766.09% 90.87%
Operating Profit -$18.93M -$61.04M
YoY Change 244.1%
Interest Expense $1.645M $16.00K -$1.639M
YoY Change -200.38% -83.67%
% of Operating Profit
Other Income/Expense, Net $20.60M -$265.0K -$602.0K
YoY Change -3522.15% 2844.44%
Pretax Income $3.318M $3.911M -$2.421M
YoY Change -237.08% -121.88%
Income Tax $57.00K $56.00K
% Of Pretax Income 1.72% 1.43%
Net Earnings $3.261M $3.855M -$2.421M
YoY Change -234.72% -121.43%
Net Earnings / Revenue 12.24% 4.23%
Basic Earnings Per Share $0.04
Diluted Earnings Per Share $17.11K $0.03 -$90.43K
COMMON SHARES
Basic Shares Outstanding 185.9M 108.1M
Diluted Shares Outstanding 114.0M

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $288.6M $288.6M $919.8K
YoY Change 31276.03% 31276.03%
Cash & Equivalents $288.6M $288.6M $58.72M
Short-Term Investments
Other Short-Term Assets $511.0K $4.432M $1.373M
YoY Change -62.78% 1309.89%
Inventory $10.38M $10.38M $6.553M
Prepaid Expenses $3.921M $1.496M
Receivables $26.78M $26.78M $16.60M
Other Receivables $0.00 $0.00
Total Short-Term Assets $330.2M $330.2M $84.74M
YoY Change 289.66% 26653.93%
LONG-TERM ASSETS
Property, Plant & Equipment $6.349M $6.349M $4.281M
YoY Change 48.31%
Goodwill $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments $215.1M
YoY Change
Other Assets $776.0K $776.0K $584.0K
YoY Change 32.88%
Total Long-Term Assets $7.125M $7.125M $4.865M
YoY Change 46.45% -96.69%
TOTAL ASSETS
Total Short-Term Assets $330.2M $330.2M $84.74M
Total Long-Term Assets $7.125M $7.125M $4.865M
Total Assets $337.3M $337.3M $89.60M
YoY Change 276.45% 55.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.40M $11.40M $3.369M
YoY Change 238.47% 9784.71%
Accrued Expenses $7.411M $7.411M $8.168M
YoY Change -9.27% 29722.94%
Deferred Revenue $6.288M $6.196M
YoY Change 1.48%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.41M $25.41M $18.03M
YoY Change 40.92% 18024.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $5.022M
YoY Change -100.0%
Other Long-Term Liabilities $2.646M $67.73M $545.0K
YoY Change 385.5% 166.38%
Total Long-Term Liabilities $2.646M $67.73M $5.567M
YoY Change -52.47% 166.38%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.41M $25.41M $18.03M
Total Long-Term Liabilities $2.646M $67.73M $5.567M
Total Liabilities $93.15M $93.15M $27.58M
YoY Change 237.75% 264.31%
SHAREHOLDERS EQUITY
Retained Earnings -$75.71M -$79.56M
YoY Change -4.85%
Common Stock $19.00K $4.000K
YoY Change 375.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $244.2M $244.2M -$75.47M
YoY Change
Total Liabilities & Shareholders Equity $337.3M $337.3M $89.60M
YoY Change 276.45% 55.94%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income $3.261M $3.855M -$2.421M
YoY Change -234.72% -121.43%
Depreciation, Depletion And Amortization $451.0K $1.720M
YoY Change -4.18%
Cash From Operating Activities -$6.907M -$45.70M -$221.1K
YoY Change 3024.63% 607.57%
INVESTING ACTIVITIES
Capital Expenditures -$1.465M $3.788M
YoY Change 491.88%
Acquisitions $0.00
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$1.465M -$3.788M $0.00
YoY Change 625.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $45.00M
YoY Change 5347.94%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 240.0K 279.4M 75.00K
YoY Change 220.0% 4612.85%
NET CHANGE
Cash From Operating Activities -6.907M -45.70M -221.1K
Cash From Investing Activities -1.465M -3.788M 0.000
Cash From Financing Activities 240.0K 279.4M 75.00K
Net Change In Cash -8.132M 229.9M -146.1K
YoY Change 5467.96% -21931.72%
FREE CASH FLOW
Cash From Operating Activities -$6.907M -$45.70M -$221.1K
Capital Expenditures -$1.465M $3.788M
Free Cash Flow -$5.442M -$49.49M
YoY Change 597.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 mkfg Proceeds From Pipe Investment
ProceedsFromPIPEInvestment
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 mkfg Transaction Costs
TransactionCosts
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001816613
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 mkfg Transaction Costs Expensed
TransactionCostsExpensed
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
CY2020 mkfg Proceeds From Merger
ProceedsFromMerger
CY2020 mkfg Officers Compensation162 M
OfficersCompensation162M
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
001-39453
CY2021 dei Entity Registrant Name
EntityRegistrantName
Markforged Holding Corporation
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1545859
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
480 Pleasant Street
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
CY2021 dei City Area Code
CityAreaCode
866
CY2021 dei Local Phone Number
LocalPhoneNumber
496-1805
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
true
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
214800000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
187102821
CY2021 dei Auditor Firm
AuditorFirmId
238
CY2021 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2021 dei Auditor Location
AuditorLocation
Boston, Massachusetts
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288603000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58715000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26777000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16601000
CY2021Q4 us-gaap Inventory Net
InventoryNet
10377000
CY2020Q4 us-gaap Inventory Net
InventoryNet
6553000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3921000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1496000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
511000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1373000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
330189000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
84738000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6349000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4281000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
776000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
584000
CY2021Q4 us-gaap Assets
Assets
337314000
CY2020Q4 us-gaap Assets
Assets
89603000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
11403000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3369000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7411000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8168000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6288000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
6196000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
310000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
300000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
25412000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18033000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5022000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3742000
CY2020 us-gaap Revenues
Revenues
71851000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2905000
CY2021Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1623000
CY2020Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
1073000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
59722000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2646000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
545000
CY2021Q4 us-gaap Liabilities
Liabilities
93145000
CY2020Q4 us-gaap Liabilities
Liabilities
27578000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
0
CY2020Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
137497000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
183300000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
185993058
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39510108
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
19000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
319859000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5538000
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
0
CY2020Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
483479
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0
CY2020Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1450000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-75709000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-79564000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
244169000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-75472000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
337314000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
89603000
CY2021 us-gaap Revenues
Revenues
91221000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
38368000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
29921000
CY2021 us-gaap Gross Profit
GrossProfit
52853000
CY2020 us-gaap Gross Profit
GrossProfit
41930000
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
35966000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
22413000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32155000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
17176000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
45772000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20080000
CY2021 us-gaap Operating Expenses
OperatingExpenses
113893000
CY2020 us-gaap Operating Expenses
OperatingExpenses
59669000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-61040000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-17739000
CY2021 mkfg Fair Value Adjustment Of Derivative Liabilities
FairValueAdjustmentOfDerivativeLiabilities
1808000
CY2020 mkfg Fair Value Adjustment Of Derivative Liabilities
FairValueAdjustmentOfDerivativeLiabilities
-175000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-63407000
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-265000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9000
CY2021 us-gaap Interest Expense
InterestExpense
16000
CY2020 us-gaap Interest Expense
InterestExpense
98000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
17000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
147000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3911000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17874000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
56000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
111000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3855000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-17985000
CY2021 mkfg Deemed Dividend Redemption Of Common Stock
DeemedDividendRedemptionOfCommonStock
0
CY2020 mkfg Deemed Dividend Redemption Of Common Stock
DeemedDividendRedemptionOfCommonStock
826000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3855000
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18811000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108088115
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38336659
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113963424
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38336659
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-60361000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1131000
CY2020 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
826000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2569000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-17985000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-75472000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1967000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11881000
CY2021 mkfg Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1793000
CY2021 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
138047000
CY2021 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
45000000
CY2021 mkfg Stock Issued During Period Value Reverse Recapitalization
StockIssuedDuringPeriodValueReverseRecapitalization
113178000
CY2021 mkfg Stock Issued During Period Value Pipe Investment
StockIssuedDuringPeriodValuePIPEInvestment
210000000
CY2021 mkfg Adjustments To Additional Paid In Capital Recognition Of Derivative Liabilities Related To Earnout
AdjustmentsToAdditionalPaidInCapitalRecognitionOfDerivativeLiabilitiesRelatedToEarnout
-123129000
CY2021 mkfg Adjustments To Additional Paid In Capital Share Based Compensation Earnout Shares Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEarnoutSharesRequisiteServicePeriodRecognition
7049000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3855000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
244169000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3855000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-17985000
CY2021 us-gaap Depreciation
Depreciation
1720000
CY2020 us-gaap Depreciation
Depreciation
1795000
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
263000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
591000
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
151000
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
37000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1808000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
175000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-63407000
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
18930000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2569000
CY2021 mkfg Transaction Costs Expensed
TransactionCostsExpensed
1996000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10439000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-967000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3975000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
808000
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2425000
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
333000
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-862000
CY2020 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-840000
CY2021 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
191000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-49000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7277000
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
852000
CY2021 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
10000
CY2020 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-366000
CY2021 mkfg Increase Decrease In Deferred Rent Credit Non Current
IncreaseDecreaseInDeferredRentCreditNonCurrent
550000
CY2020 mkfg Increase Decrease In Deferred Rent Credit Non Current
IncreaseDecreaseInDeferredRentCreditNonCurrent
100000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
929000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
5058000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-45702000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6459000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3788000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
640000
CY2021 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0
CY2020 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
118000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3788000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-522000
CY2021 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-5022000
CY2020 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
5022000
CY2021 mkfg Proceeds From Merger
ProceedsFromMerger
132926000
CY2021 mkfg Proceeds From Pipe Investment
ProceedsFromPIPEInvestment
210000000
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
45000000
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
826000
CY2021 us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
16043000
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
550000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
700000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1967000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1131000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
98000
CY2021 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
0
CY2020 us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
1000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
279378000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5928000
CY2021 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
229888000
CY2020 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1053000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58715000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59768000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
288603000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
58715000
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-84000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
532000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0
CY2021 mkfg Recognition Of Contingent Earnout Liability Related To Earnout Shares
RecognitionOfContingentEarnoutLiabilityRelatedToEarnoutShares
123129000
CY2020 mkfg Recognition Of Contingent Earnout Liability Related To Earnout Shares
RecognitionOfContingentEarnoutLiabilityRelatedToEarnoutShares
0
CY2021 mkfg Recognition Of One Public Warrant Acquired As Part Of The Merger In Additional Paid In Capital
RecognitionOfOnePublicWarrantAcquiredAsPartOfTheMergerInAdditionalPaidInCapital
9729000
CY2020 mkfg Recognition Of One Public Warrant Acquired As Part Of The Merger In Additional Paid In Capital
RecognitionOfOnePublicWarrantAcquiredAsPartOfTheMergerInAdditionalPaidInCapital
0
CY2021 mkfg Recognition Of Private Placement Warrant Liability Upon Merger
RecognitionOfPrivatePlacementWarrantLiabilityUponMerger
5702000
CY2020 mkfg Recognition Of Private Placement Warrant Liability Upon Merger
RecognitionOfPrivatePlacementWarrantLiabilityUponMerger
0
CY2021 mkfg Exercise Of Common Stock Warrants Net Of Shares Withheld For Exercise
ExerciseOfCommonStockWarrantsNetOfSharesWithheldForExercise
1793000
CY2020 mkfg Exercise Of Common Stock Warrants Net Of Shares Withheld For Exercise
ExerciseOfCommonStockWarrantsNetOfSharesWithheldForExercise
0
CY2021 mkfg Conversion Of Convertible Preferred Stock Into Common Stock Upon Reverse Recapitalization
ConversionOfConvertiblePreferredStockIntoCommonStockUponReverseRecapitalization
138047000
CY2020 mkfg Conversion Of Convertible Preferred Stock Into Common Stock Upon Reverse Recapitalization
ConversionOfConvertiblePreferredStockIntoCommonStockUponReverseRecapitalization
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 mkfg Business Acquisition Common Stock Exchange Ratio
BusinessAcquisitionCommonStockExchangeRatio
0.9522514
CY2021Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
143795504
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5220000
CY2021Q3 mkfg Legacy Markforged Shares
LegacyMarkforgedShares
143795504
CY2021Q3 mkfg Common Stock Shares Issued Immediately After Merger
CommonStockSharesIssuedImmediatelyAfterMerger
185251837
CY2021Q3 mkfg Contingent Forfeited Sponsor Shares Pending Sponsor Earnout Triggering Event
ContingentForfeitedSponsorSharesPendingSponsorEarnoutTriggeringEvent
2610000
CY2021Q3 mkfg Convertible Legacy Markforged Shares
ConvertibleLegacyMarkforgedShares
151005831
CY2021Q3 mkfg Proceeds From Merger Including Contribution Cash Held In Trust
ProceedsFromMergerIncludingContributionCashHeldInTrust
360900000
CY2021Q3 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
215100000
CY2021Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount
SharesSubjectToMandatoryRedemptionSettlementTermsAmount
64200000
CY2021Q3 mkfg Cash In Connection With Pipe Financing
CashInConnectionWithPipeFinancing
210000000.0
CY2021Q3 us-gaap Payments For Merger Related Costs
PaymentsForMergerRelatedCosts
34500000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management’s significant estimates include allowance for doubtful accounts, reserve for excess and obsolete inventory, fair value of contingent earnout liability, fair value of earnout share awards, fair value of the private placement warrant liability and assumptions in revenue recognition. Actual results could differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021 us-gaap Advertising Expense
AdvertisingExpense
6000000.0
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1070000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1038000
CY2021 mkfg Accounts Receivable Allowance For Credit Loss Additions
AccountsReceivableAllowanceForCreditLossAdditions
709000
CY2020 mkfg Accounts Receivable Allowance For Credit Loss Additions
AccountsReceivableAllowanceForCreditLossAdditions
834000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
312000
CY2020 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
257000
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
446000
CY2020 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
545000
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1021000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1070000
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Concentration of Credit Risk</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments which potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents held on deposit at one financial institution and accounts receivable. The Company does not require collateral from customers for amounts owed. At December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> customer represented greater than </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the accounts receivable balance. There were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> customers representing greater than </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the accounts receivable balance as of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2020. For the years ended December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> one customer represented more than </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of total revenue. Historically, the Company has not experienced any significant credit loss related to any individual customer.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2020 us-gaap Advertising Expense
AdvertisingExpense
3000000.0
CY2020Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
564000
CY2019Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
1260000
CY2021 us-gaap Extended Product Warranty Accrual Warranties Issued
ExtendedProductWarrantyAccrualWarrantiesIssued
529000
CY2020 us-gaap Extended Product Warranty Accrual Warranties Issued
ExtendedProductWarrantyAccrualWarrantiesIssued
821000
CY2021 us-gaap Extended Product Warranty Accrual Payments
ExtendedProductWarrantyAccrualPayments
435000
CY2020 us-gaap Extended Product Warranty Accrual Payments
ExtendedProductWarrantyAccrualPayments
882000
CY2021 us-gaap Extended Product Warranty Accrual Preexisting Increase Decrease
ExtendedProductWarrantyAccrualPreexistingIncreaseDecrease
0
CY2020 us-gaap Extended Product Warranty Accrual Preexisting Increase Decrease
ExtendedProductWarrantyAccrualPreexistingIncreaseDecrease
-635000
CY2021Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
658000
CY2020Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
564000
CY2021 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
0
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
12475000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8687000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6126000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4406000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6349000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4281000
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5900000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2100000
CY2021Q4 us-gaap Contractual Obligation Due In Next Twelve Months
ContractualObligationDueInNextTwelveMonths
6300000
CY2021Q4 us-gaap Contractual Obligation Due In Second Year
ContractualObligationDueInSecondYear
2400000
CY2021Q4 us-gaap Contractual Obligation Due In Third Year
ContractualObligationDueInThirdYear
1100000
CY2021Q4 mkfg Contractual Obligation Due After Third Year
ContractualObligationDueAfterThirdYear
200000
CY2021Q4 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P1Y
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91221000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71851000
CY2021 mkfg Depreciation Expense
DepreciationExpense
1700000
CY2020 mkfg Depreciation Expense
DepreciationExpense
1800000
CY2021 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
0
CY2020 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
100000
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
853000
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1669000
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
77000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
79000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
9447000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4805000
CY2021Q4 us-gaap Inventory Net
InventoryNet
10377000
CY2020Q4 us-gaap Inventory Net
InventoryNet
6553000
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1000000.0
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
800000
CY2021 mkfg Finished Goods Impairment Charges
FinishedGoodsImpairmentCharges
800000
CY2021 mkfg Raw Materials Impairment Charges
RawMaterialsImpairmentCharges
200000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
658000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
564000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4360000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3100000
CY2021Q4 mkfg Var Commissions
VarCommissions
265000
CY2020Q4 mkfg Var Commissions
VarCommissions
520000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1725000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2907000
CY2021Q4 mkfg Accrued Marketing And Advertising Costs Current
AccruedMarketingAndAdvertisingCostsCurrent
122000
CY2020Q4 mkfg Accrued Marketing And Advertising Costs Current
AccruedMarketingAndAdvertisingCostsCurrent
780000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
281000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
297000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7411000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
8168000
CY2020Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
113419184
CY2020Q4 mkfg Temporary Equity Shares Issued And Outstanding
TemporaryEquitySharesIssuedAndOutstanding
107592801
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
137497000
CY2020Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
137876000
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
56394803
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
130804276
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
55200000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
1100000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0020
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.0139
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.0024
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18930000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2569000
CY2021 mkfg Earnout Period
EarnoutPeriod
P5Y
CY2021Q4 us-gaap Share Price
SharePrice
5.37
CY2021Q3 us-gaap Share Price
SharePrice
8.56
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7000
CY2021 mkfg Officers Compensation162 M
OfficersCompensation162M
0.2636
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.1195
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.0348
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3.5634
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.2518
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.0326
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0119
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0085
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M14D
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
3685000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-18269000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
226000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
395000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3911000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17874000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1000
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
5000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
55000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
106000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
56000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
111000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
56000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
111000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.2100
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.5105
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0185
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.2608
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.0106
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.0144
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
0.0061
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
-0.0117
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Settlements
EffectiveIncomeTaxRateReconciliationTaxSettlements
0.0046
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-3.3750
CY2021 mkfg Transaction Costs
TransactionCosts
-0.2585
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
647000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
560000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
369000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
453000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2138000
CY2021Q4 mkfg Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
21000
CY2020Q4 mkfg Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
-39000
CY2021Q4 mkfg Deferred Tax Liabilities Unrealized Foreign Currency Loss
DeferredTaxLiabilitiesUnrealizedForeignCurrencyLoss
0
CY2020Q4 mkfg Deferred Tax Liabilities Unrealized Foreign Currency Loss
DeferredTaxLiabilitiesUnrealizedForeignCurrencyLoss
-3000
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
372000
CY2021Q4 mkfg Deferred Tax Assets Uniform Capitalization
DeferredTaxAssetsUniformCapitalization
74000
CY2020Q4 mkfg Deferred Tax Assets Uniform Capitalization
DeferredTaxAssetsUniformCapitalization
45000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27846000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
16266000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3717000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3232000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
35988000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
21546000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
36009000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
21507000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0139
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0094
CY2021Q4 mkfg Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
174000
CY2020Q4 mkfg Deferred Tax Assets Amortization
DeferredTaxAssetsAmortization
23000
CY2021Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
577000
CY2020Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
318000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
446000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense
DeferredTaxAssetsTaxDeferredExpense
280000
CY2020Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
99500000
CY2021Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
0
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
36000000.0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
21466000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
17001000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
14543000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
4465000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
36009000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
21466000
CY2021 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2500000
CY2020 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
2200000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
5499000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
8314000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
7507000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
7594000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
7775000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
31412000
CY2021Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
68101000
CY2021Q4 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
0
CY2021Q4 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
0
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3855000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-17985000
CY2021 mkfg Deemed Dividend Redemption Of Common Stock
DeemedDividendRedemptionOfCommonStock
0
CY2020 mkfg Deemed Dividend Redemption Of Common Stock
DeemedDividendRedemptionOfCommonStock
826000
CY2021 mkfg Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
3855000
CY2020 mkfg Net Income Loss Available To Common Stockholders Basic And Diluted
NetIncomeLossAvailableToCommonStockholdersBasicAndDiluted
-18811000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108088115
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38336659
CY2021 mkfg Weighted Average Number Of Unvested Options Shares Outstanding
WeightedAverageNumberOfUnvestedOptionsSharesOutstanding
5875309
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
113963424
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38336659
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.49
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.49
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
27529223
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
121790215
CY2021 us-gaap Revenues
Revenues
91221000
CY2020 us-gaap Revenues
Revenues
71851000

Files In Submission

Name View Source Status
0000950170-22-005169-index-headers.html Edgar Link pending
0000950170-22-005169-index.html Edgar Link pending
0000950170-22-005169.txt Edgar Link pending
0000950170-22-005169-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mkfg-20211231.htm Edgar Link pending
mkfg-20211231.xsd Edgar Link pending
mkfg-20211231_cal.xml Edgar Link unprocessable
mkfg-20211231_def.xml Edgar Link unprocessable
mkfg-20211231_htm.xml Edgar Link completed
mkfg-20211231_lab.xml Edgar Link unprocessable
mkfg-20211231_pre.xml Edgar Link unprocessable
mkfg-ex10_12.htm Edgar Link pending
mkfg-ex23_1.htm Edgar Link pending
mkfg-ex31_1.htm Edgar Link pending
mkfg-ex31_2.htm Edgar Link pending
mkfg-ex32_1.htm Edgar Link pending
mkfg-ex32_2.htm Edgar Link pending
mkfg-ex4_3.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending